Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation

被引:51
作者
Canales, M.
Youssef, P.
Spong, R.
Ishani, A.
Savik, K.
Hertz, M.
Ibrahim, H. N.
机构
[1] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Nursing, Minneapolis, MN USA
关键词
chronic kidney disease; heart-lung transplantation; long-term survivors; lung transplantation; RENAL-FUNCTION LOSS; DIABETIC-NEPHROPATHY; RECIPIENTS; SIROLIMUS; FAILURE; IRBESARTAN; IMPACT; COMPLICATIONS; INSUFFICIENCY; CYCLOSPORINE;
D O I
10.1111/j.1600-6143.2006.01458.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Renal insufficiency is common after non-renal organ transplants. The predictors of long-term renal outcomes are not well established. A total of 219 lung and heart-lung transplant recipients surviving more than 6 months after transplantation were studied to determine predictors of time to doubling of serum creatinine and end-stage kidney disease (ESKD) with death as a competing risk. Median follow-up was 79 months (range 9-222 months). Baseline estimated glomerular filtration rate (GFR) was 96.3 +/- 34.5 mL/min/1.73 m(2). One hundred twenty-two recipients (55%) doubled their serum creatinine, 16 (7.3%) progressed to ESKD and 143 (65%) died. The majority of recipients who survived > 6 years had a GFR < 60 mL/min at both 1 and 7 years. Most of the loss of renal function occurred in the first year post-transplant. Older age at transplant, lower GFR at 1 month and cyclosporine use in the first 6 months predicted shorter time to doubling of serum creatinine when death was handled as a competing risk. Based on this prevalence data and using GFR decay and death as study endpoints, we offer sample size estimates for a prospective, interventional trial that is aimed at slowing or preventing the progression of kidney disease.
引用
收藏
页码:2157 / 2163
页数:7
相关论文
共 46 条
[1]   Kidney disease after heart and lung transplantation [J].
Bloom, RD ;
Doyle, AM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) :671-679
[2]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[3]  
Broekroelofs J, 2000, TRANSPLANTATION, V69, P1624
[4]   Prevention of renal function loss after non-renal solid organ transplantation - how can nephrologists help to keep the kidneys out of the line of fire? [J].
Broekroelofs, J ;
Stegeman, CA ;
Navis, G ;
de Jong, PE .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) :1841-1843
[5]   Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable? [J].
Broekroelofs, J ;
Stegeman, CA ;
Navis, GJ ;
de Haan, J ;
van der Bij, W ;
de Boer, WJ ;
de Zeeuw, D ;
de Jong, PE .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (03) :256-262
[6]   Lung transplantation [J].
Broekroelofs, J ;
Navis, G ;
Stegeman, CA ;
van der Bij, W ;
de Jong, PE .
LANCET, 1998, 351 (9108) :1064-1064
[7]  
Canales M, 2005, AM J TRANSPLANT, V5, P346
[8]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[9]   Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[10]   Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future [J].
de Mattos, AM ;
Olyaei, AJ ;
Bennett, WM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) :333-346